Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (8315)	1/16/1999 3:20:00 PM
From: aknahow	Read Replies (2) \| Respond to of 17367

Bob, am having trouble with my e-mail both receiving and sending. Big delays. Hope by now you are aware that even with zero deaths in treatment group the trial would not be stopped until X number of total deaths occurred. Suppose there were 0 in the treatment group and 5 in the placebo with 100 people in each group. No stop. If 300 accrued with zero in treatment and 7 in placebo. No stop. Ellen said the total of required deaths includes both groups. She confirmed this to Greg. This is indeed counter intuitive but one of my e-mails explained why XOMA might have accepted a total death figure rather than getting stuck with that figure after trying to get the treatment deaths excluded. Murphy has a call in hot line on Wed and Fri. Comments came after the market close.